U003 - Optimal Management of Pediatric Morphea
Friday, February 16; 7:30 AM - 8:30 AM
Following this course, the attendee should be able to:
- Recognize patients at increased risk of extracutaneous manifestations
- Perform appropriate diagnostic workup for children with morphea
- Confidently treat severe pediatric morphea with systemic therapy
Evolving research in pediatric morphea has expanded understanding of this disorder. This session will highlight the latest literature and provide guidance on optimal management based on current evidence. Linear morphea is the most common subtype present in children and is associated with the highest morbidity. A suggested algorithm for workup and monitoring of extracutaneous manifestations will be presented. Selection of optimal therapy and nuances in the use of systemic agents such as methotrexate will be reviewed.
- Chiu, Yvonne, MD: Novan – Data Safety Monitoring Board(Fees);